Barbara Weber

Executive Chairman

Board Member Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Tango Therapeutics, Inc. (TNGX)	Executive Chairman	$697,950	—	$308,096	$1,275,328	$524,250	$18,368	$2,823,992
2024	Tango Therapeutics, Inc. (TNGX)	President, Chief Executive Officer and Director	$659,996	—	$1,070,423	$4,345,288	$447,477	$18,016	$6,541,200
2023	Tango Therapeutics, Inc. (TNGX)	President, Chief Executive Officer and Director	$625,997	—	$465,634	$1,885,613	$396,576	$17,238	$3,391,059
2022	Tango Therapeutics, Inc. (TNGX)	President, Chief Executive Officer and Director	$575,000	—	—	$3,740,625	$363,688	$2,474	$4,681,787
2021	Tango Therapeutics, Inc. (TNGX)	President, Chief Executive Officer and Director	$513,685	—	—	$10,719,769	$277,910	$4,609	$11,515,974
2020	Tango Therapeutics, Inc. (TNGX)	President, Chief Executive Officer and Director	$491,617	—	—	$227,622	$226,194	$12,788	$958,221

Executive changes

Resigned member of Company's board of directors at Tango Therapeutics, Inc. (TNGX)
2026-08-03
Resigned Executive Chair at Tango Therapeutics, Inc. (TNGX)
2026-08-03
Resigned director at Revolution Medicines, Inc. (RVMD)
2025-06-26

Earnings-call appearances

No earnings-call appearances recorded yet.